Recommendations for the use of LDL apheresis

Atherosclerosis

Volumn 198, Issue 2, 2008, Pages 247-255

  Thompson, G R ^a  

^a NONE

Author keywords

DALI; Dextran sulphate adsorption; Double filtration thermofiltration plasmapheresis; Familial hypercholesterolaemia; Guidelines; HELP; Immunoadsorption; Lp(a)

Indexed keywords

ANTILIPEMIC AGENT; BILE ACID SEQUESTRANT; CELLULOSE; CHOLESTEROL; DEXTRAN SULFATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROBUCOL;

ANGIOCARDIOGRAPHY; APHERESIS; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONFLICT OF INTEREST; CORONARY ARTERY DISEASE; DISEASE COURSE; DOUBLE FILTRATION PLASMAPHERESIS; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; HEART DEATH; HEMOPERFUSION; HETEROZYGOTE; HUMAN; IMMUNOADSORPTION; PLASMAPHERESIS; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; REVIEW; THERMOFILTRATION PLASMAPHERESIS; TREATMENT INDICATION; VASCULAR ENDOTHELIUM;

BLOOD COMPONENT REMOVAL; CARDIOVASCULAR DISEASES; CHILD; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEINS, LDL; PRACTICE GUIDELINES AS TOPIC; PREGNANCY;

EID: 44149123549     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.02.009     Document Type: Review

References (51)

1. Thompson G.R., Lowenthal R., and Myant R. Plasma exchange in the management of homozygous familial hypercholesterolaemia. Lancet 1 (1975) 1208-1211
2. Thompson G.R., Myant N.B., Kilpatrick D., Oakley C.M., Raphael M.J., and Steiner R.E. Assessment of long-term plasma exchange for familial hypercholesterolaemia. Br Heart J 43 (1980) 680-688
3. Thompson G.R., Miller J.P., and Breslow J.L. Improved survival of patients with homozygous familial hypercholesterolaemia treated by plasma exchange. Br Med J 291 (1985) 1671-1673
4. Stoffel W., Borberg H., and Greve V. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolaemia. Lancet 2 (1981) 1005-1007
5. Yokoyama S., Hayashi R., Satani M., and Yamamoto A. Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis 5 (1985) 613-622
6. Mabuchi H., Michishita I., Takeda M., et al. A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis). Atherosclerosis 68 (1989) 19-26
7. Eisenhauer T., Armstrong V.W., Wieland H., Fuchs C., Scheler F., and Seidel D. Selective removal of low density lipoproteins (LDL) by precipitation at low pH; first clinical application of the HELP system. Klin Woch 65 (1987) 161-168
8. Klingel R., Mausfeld P., Fassbender C., and Goehlen B. Lipidfiltration-safe and effective methodology to perform lipid-apheresis. Transfus Apher Sci 30 (2004) 245-254
9. Bosch T., Schmidt B., Kleophas W., Otto V., and Samtleben W. LDL hemoperfusion-a new procedure for LDL apheresis: biocompatibility results from a first pilot study in hypercholesterolemic atherosclerosis in patients. Artif Organs 21 (1997) 1060-1065
10. Kobayashi A., Nakatani M., Furuyoshi S., and Tani M. In vitro evaluation of dextran sulphate cellulose beads for whole blood infusion low-density lipoprotein-hemoperfusion. Ther Apher 6 (2002) 365-371
11. Richter W.O., Jacob B.G., Ritter M.M., Sühler K., Vierneisel K., and Schwandt P. Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies. Metabolism 42 (1993) 888-894
12. Gordon B.R., Kelsey S.F., Dau P.C., et al., for the Liposorber Study Group. Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Am J Cardiol 81 (1998) 407-411
13. Krebs A., Krebs K., and Keller F. Retrospective comparison of 5 different methods for long-term LDL-apheresis in 20 patients between 1986 and 2001. Int J Artif Organs 27 (2004) 137-148
14. Julius U., Metzler W., Pietzsch J., Fassbender T., and Klingel R. Intraindividual comparison of two extracorporeal LDL apheresis methods:lipidfiltration and HELP. Int J Artif Organs 25 (2002) 1180-1188
15. Bosch T., Schmidt B., Blumenstein M., and Gurland H.J. Lipid apheresis by hemoperfusion: in vitro efficacy and ex vivo biocompatibility of a new low-density lipoprotein adsorber compatible with human whole blood. Artif Organs 17 (1993) 640-652
16. Richter W.O., Donner M.G., and Schwandt P. Three low density lipoprotein apheresis techniques in treatment of patients with familial hypercholesterolemia: a long-term evaluation. Ther Apher 3 (1999) 203-208
17. Tamai O., Matsuoka H., Itabe H., Wada Y., Kohno K., and Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation 95 (1997) 76-82
18. Rubba P., Faccenda F., Di Soma S., et al. Cerebral blood flow velocity and systemic vascular resistance after acute reduction of low-density lipoprotein in familial hypercholesterolemia. Stroke 24 (1993) 1154-1161
19. Rubba P., Iannuzzi A., Postiglione A., et al. Hemodynamic changes in the peripheral circulation after repeat low density lipoprotein apheresis in familial hypercholesterolemia. Circulation 81 (1990) 610-616
20. Aengevaeren W.R.M., Kroon A.A., Stalenhoef A.F.H., Uijen G.J.H., and Van der Werf T. Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. JACC 28 (1996) 1696-1704
21. Thompson G.R. LDL apheresis. Atherosclerosis 167 (2003) 1-13
22. Naoumova R.P., Thompson G.R., and Soutar A.K. Current management of severe homozygous hypercholesterolaemias. Curr Opin Lipidol 15 (2004) 413-422
23. Kawaguchi A., Yutani C., and Yamamoto A. Hypercholesterolemic valvulopathy: an aspect of malignant atherosclerosis. Ther Apher Dial 7 (2003) 439-443
24. Klingel R., Gohlen B., Schwarting A., et al. Differential indication of lipoprotein apheresis during pregnancy. Ther Apher Dial 7 (2003) 359-364
25. Makino H., and Harada-Shiba M. Long-term effect of low-density lipoprotein apheresis in patients with homozygous familial hypercholesterolemia. Ther Apher Dial 7 (2003) 397-401
26. Tatami R., Inoue N., Itoh H., et al. Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study. The LARS Investigators. Atherosclerosis 95 (1992) 1-13
27. Kitabatake A., Sato H., Hori M., et al., The Osaka LDL-Apheresis Multicenter Trial Group. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. Clin Ther 16 (1994) 416-428
28. Waidner T., Franzen D., Voelker W., et al. The effect of LDL apheresis on progression of coronary artery disease in patients with familial hypercholesterolemia. Results of a multicenter LDL apheresis study. Clin Invest 72 (1994) 858-863
29. Schuff-Werner P., Gohlke H., Bartmann U., and The HELP-Study Group. The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL apheresis in the secondary prevention of coronary heart disease. Part II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease. Heparin-induced extra-corporeal LDL-precipitation. Eur J Clin Invest 24 (1994) 724-732
30. Thompson G.R., Maher V.M., Matthews S., et al. Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis. Lancet 345 (1995) 811-816
31. Kroon A.A., Aengevaeren W.R., van der Werf T., et al. LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation 93 (1996) 1826-1835
32. Richter W.O., Donner M.G., Hofling B., and Schwandt P. Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia. Metabolism 47 (1998) 863-868
33. Nishimura S., Sekiguchi M., Kano T., et al. Effects of intensive lipid lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan low-density lipoprotein apheresis coronary atherosclerosis prospective study (L-CAPS). Atherosclerosis 144 (1999) 409-417
34. Brensike J.F., Levy R.I., Kelsey S.F., et al. Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study. Circulation 69 (1984) 313-324
35. Kane J.P., Malloy M.J., Ports T.A., Phillips N.R., Diehl J.C., and Havel R.J. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 264 (1990) 3007-3012
36. Matsuzaki M., Hiramori K., Imaizumi T., et al. Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia. J Am Coll Cardiol 40 (2002) 220-227
37. Park J.W., Merz M., and Braun P. Regression of transplant coronary artery disease during chronic low-density lipoprotein-apheresis. J Heart Lung Transplant 16 (1997) 290-297
38. Mabuchi H., Koizumi J., Shimizu M., et al., Hokuriku-FH-LDL-Apheresis Study Group. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Am J Cardiol 82 (1998) 1489-1495
39. Kroon A.A., van Asten W.N., and Stalenhoef A.F. Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease. Ann Intern Med 125 (1996) 945-954
40. Koga N., Watanabe K., Kurashige Y., Sato T., and Hiroki T. Long-term effects of LDL apheresis on carotid arterial atherosclerosis in familial hypercholesterolaemic patients. J Intern Med 246 (1999) 35-43
41. Vella A., Pineda A.A., and O'Brien T. Low-density lipoprotein apheresis for the treatment of refractory hyperlipidemia. Mayo Clin Proc 76 (2001) 1039-1046
42. Moriarty P.M., and Gibson C.A. Low-density lipoprotein apheresis in the treatment of atherosclerosis and other potential uses. Curr Atheroscler Rep 3 (2001) 156-162
43. Bosch T., and Wendler T. State of the art of low-density lipoprotein apheresis in the year 2003. Ther Apher Dial 8 (2004) 76-79
44. Mabuchi H., Higashikata T., and Kawashiri M.A. Clinical applications of long-term LDL-apheresis on and beyond refractory hypercholesterolemia. Transfus Apher 30 (2004) 233-243
45. Morelli F., Carlier P., Giannini G., et al. Hypercholesterolemia and LDL apheresis. Int J Artif Organs 28 (2005) 1025-1031
46. Thompsen J., and Thompson P.D. A systematic review of LDL apheresis in the treatment of cardiovascular disease. Atherosclerosis 189 (2006) 31-38
47. Forms of Therapeutic Hemopheresis. Summary Report of the Working Party on Medical Treatment of the Federal Committee of Physicians and Health Insurance Companies on the Deliberations Pursuant to § 135 para 1 of the Code of Social Law, vol V (SGB V), 2003.
48. Civiera F., and for International Panel on Management of Familial Hypercholesterolemia. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis 173 (2004) 55-68
49. Kavey R.-E.W., Allada V., Daniels S.R., et al. Cardiovascular risk reduction in high-risk pediatric patients. A Scientific Statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; the Interdisciplinary Working Group on Quality of Care and Outcomes Research. Circulation 114 (2006) 2710-2738
50. Szczepiorkowski Z.M., Bandarenko M., Kim H.C., et al. Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the apheresis applications committee of the American society for apheresis. J Clin Apher 22 (2007) 106-175
51. Mowatt G., Vale L., and MacLeod A. Systematic review of the effectiveness of home versus hospital or satellite unit hemodialysis for people with end-stage renal failure. Int J Technol Assess Health Care 20 (2004) 258-268